help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, Y.-H.
Right arrow Articles by Cowan, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, Y.-H.
Right arrow Articles by Cowan, D. B.
(American Journal of Pathology. 2006;169:72-85.)
© 2006 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2006.051163

Cardiac Conduction through Engineered Tissue

Yeong-Hoon Choi*, Christof Stamm*, Peter E. Hammer*{dagger}, Kevin F. Kwaku{ddagger}, Jennifer J. Marler§, Ingeborg Friehs*, Mara Jones{dagger}, Christine M. Rader*{dagger}, Nathalie Roy*, Mau-Thek Eddy{dagger}, John K. Triedman, Edward P. Walsh, Francis X. McGowan, Jr.{dagger}, Pedro J. del Nido* and Douglas B. Cowan{dagger}

From the Departments of Cardiac Surgery,* Anesthesiology,{dagger} Surgery,§ and Cardiology, Children’s Hospital Boston, and the Cardiovascular Division,{ddagger} Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

In children, interruption of cardiac atrioventricular (AV) electrical conduction can result from congenital defects, surgical interventions, and maternal autoimmune diseases during pregnancy. Complete AV conduction block is typically treated by implanting an electronic pacemaker device, although long-term pacing therapy in pediatric patients has significant complications. As a first step toward developing a substitute treatment, we implanted engineered tissue constructs in rat hearts to create an alternative AV conduction pathway. We found that skeletal muscle-derived cells in the constructs exhibited sustained electrical coupling through persistent expression and function of gap junction proteins. Using fluorescence in situ hybridization and polymerase chain reaction analyses, myogenic cells in the constructs were shown to survive in the AV groove of implanted hearts for the duration of the animal’s natural life. Perfusion of hearts with fluorescently labeled lec-tin demonstrated that implanted tissues became vascularized and immunostaining verified the presence of proteins important in electromechanical integration of myogenic cells with surrounding re-cipient rat cardiomyocytes. Finally, using optical mapping and electrophysiological analyses, we provide evidence of permanent AV conduction through the implant in one-third of recipient animals. Our experiments provide a proof-of-principle that engineered tissue constructs can function as an electrical conduit and, ultimately, may offer a substitute treatment to conventional pacing therapy.




This article has been cited by other articles:


Home page
 HeartHome page
M. R Rosen
Biological pacemaking: a concept whose time has come...or is coming
Heart, February 1, 2007; 93(2): 145 - 146.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. B. Cowan and F. X. McGowan Jr
A Paradigm Shift in Cardiac Pacing Therapy?
Circulation, September 5, 2006; 114(10): 986 - 988.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society for Investigative Pathology.